In the United States, Eisai’s major products are LENVIMA® (lenvatinib), HALAVEN® (eribulin mesylate), FYCOMPA® (perampanel) and DAYVIGO™ (lemborexant). We aim to drive ongoing growth here in the world’s biggest pharmaceutical market by expanding these global brands. Our sales careers offer steady pathways to senior and leadership roles, as well as opportunities in training, marketing, and account management. Consider joining us if you possess the following knowledge and characteristics:
- Solution-oriented mindset with the experience and confidence to challenge the status quo here at Eisai and within the industry at large.
- The ability to understand and work within a complex business environment with regard to reimbursement, oral and IV brands, clinical pathways, and related functions.
- Strong commitment to our hhc mission, with the capacity to leverage internal relationships to best serve customers and patients.
The sales training team serves as strategic, results-oriented partner accountable for providing excellent foundational and enhanced training that will elevate sales team performance. We take great pride in the developmental impact we have on Eisai – by offering candid feedback, learning from our challenges, celebrating our successes, and collaborating with our stakeholders to create positive outcomes.